Bone Marrow Myeloid Cells, Frozen
Bone marrow mononuclear cells (MNCs) are separated from whole bone marrow by a density gradient centrifugation protocol. Myeloid cells are obtained by positive selection using anti-CD33 immunomagnetic beads from the MNC population. Isolated cells are characterized by the expression of CD33, CD66b and CD14 from flow cytometry prior to cryopreservation.
Since our founding in 2010, CGT Global has pursued our mission to transform healthcare as we accelerate cell and gene therapy research and clinical trials, streamline the commercialization of new treatments, and map the last mile to patient access to these life-changing remedies. By innovating each stage in the cycle; development, commercialization, and delivery, we reduce the overall cost of the care and multiply access points so that millions can receive cutting edge, life-saving gene and cell therapies.

Description
The antigens CD33 and CD66 are expressed on bone marrow derived myeloid cells such as myeloid progenitor cells, monocytes/macrophages and granulocytes (neutrophils, basophils, eosinophils). These cells play key roles in the adaptive and innate immune responses.
Bone marrow mononuclear cells (MNCs) are separated from whole bone marrow by a density gradient centrifugation protocol. Myeloid cells are obtained by positive selection using anti-CD33 immunomagnetic beads from the MNC population. Isolated cells are characterized by the expression of CD33, CD66b and CD14 from flow cytometry prior to cryopreservation.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
Additional information
Anticoagulant | |
---|---|
Format | |
Grade | |
Species | |
Cell and Tissue Source | |
Disease State | |
Donor Attributes |